-
Je něco špatně v tomto záznamu ?
Prevalence, country-specific prescribing patterns and determinants of benzodiazepine use in community-residing older adults in 7 European countries
A. Lukačišinová, J. Reissigová, M. Ortner-Hadžiabdić, J. Brkic, B. Okuyan, D. Volmer, I. Tadić, P. Modamio, EL. Mariño, K. Tachkov, R. Liperotti, G. Onder, H. Finne-Soveri, H. van Hout, EP. Howard, D. Fialová
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
Grantová podpora
CZ.02.01.01/00/22_008/0004607
NETPHARM New Technologies for Translational Research in Pharmaceutical Sciences
NLK
BioMedCentral
od 2001-01-12
BioMedCentral Open Access
od 2001
Directory of Open Access Journals
od 2001
Free Medical Journals
od 2001
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2001-01-01
Open Access Digital Library
od 2001-01-01
Open Access Digital Library
od 2001-08-01
Medline Complete (EBSCOhost)
od 2001-01-01
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
Springer Nature OA/Free Journals
od 2001-12-01
- MeSH
- benzodiazepiny * škodlivé účinky MeSH
- lidé MeSH
- prevalence MeSH
- průřezové studie MeSH
- senioři MeSH
- úzkostné poruchy * MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Evropa MeSH
BACKGROUND: The use of benzodiazepines (BZDs) in older population is often accompanied by drug-related complications. Inappropriate BZD use significantly alters older adults' clinical and functional status. This study compares the prevalence, prescribing patterns and factors associated with BZD use in community-dwelling older patients in 7 European countries. METHODS: International, cross-sectional study was conducted in community-dwelling older adults (65 +) in the Czech Republic, Serbia, Estonia, Bulgaria, Croatia, Turkey, and Spain between Feb2019 and Mar2020. Structured and standardized questionnaire based on interRAI assessment scales was applied. Logistic regression was used to evaluate factors associated with BZD use. RESULTS: Out of 2,865 older patients (mean age 73.2 years ± 6.8, 61.2% women) 14.9% were BZD users. The highest prevalence of BZD use was identified in Croatia (35.5%), Spain (33.5%) and Serbia (31.3%). The most frequently prescribed BZDs were diazepam (27.9% of 426 BZD users), alprazolam (23.7%), bromazepam (22.8%) and lorazepam (16.7%). Independent factors associated with BZD use were female gender (OR 1.58, 95%CI 1.19-2.10), hyperpolypharmacy (OR 1.97, 95%CI 1.22-3.16), anxiety (OR 4.26, 95%CI 2.86-6.38), sleeping problems (OR 4.47, 95%CI 3.38-5.92), depression (OR 1.95, 95%CI 1.29-2.95), repetitive anxious complaints (OR 1.77, 95%CI 1.29-2.42), problems with syncope (OR 1.78, 95%CI 1.03-3.06), and loss of appetite (OR 0.60, 95%CI 0.38-0.94). In comparison to Croatia, residing in other countries was associated with lower odds of BZD use (ORs varied from 0.49 (95%CI 0.32-0.75) in Spain to 0.01 (95%CI 0.00-0.03) in Turkey), excluding Serbia (OR 1.11, 95%CI 0.79-1.56). CONCLUSIONS: Despite well-known negative effects, BZDs are still frequently prescribed in older outpatient population in European countries. Principles of safer geriatric prescribing and effective deprescribing strategies should be individually applied in older BZD users.
Center for Applied Pharmacy Faculty of Pharmacy and Biochemistry University of Zagreb Zagreb Croatia
Connell School of Nursing Boston College Chestnut Hill MA USA
Department of Clinical Pharmacy Faculty of Pharmacy Marmara University Istanbul Turkey
Faculty of Medicine Institute of Pharmacy University of Tartu Tartu Estonia
Faculty of Pharmacy Medical University of Sofia Sofia Bulgaria
Faculty of Pharmacy University of Belgrade Belgrade Serbia
Finnish Institute for Health and Welfare Helsinki Finland
Fondazione Policlinico Universitario A Gemelli IRCCS Rome Italy
The Hinda and Arthur Marcus Institute for Aging Research Hebrew Senior Life Boston MA USA
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24006768
- 003
- CZ-PrNML
- 005
- 20240423155504.0
- 007
- ta
- 008
- 240412s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12877-024-04742-7 $2 doi
- 035 __
- $a (PubMed)38454372
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Lukačišinová, Anna $u Department of Social and Clinical Pharmacy - Research Group "Ageing, Polypharmacy and Changes in the Therapeutic Value of Drugs in the Aged", Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovského 1203, Hradec Králové, 500 05, Czech Republic. lukacisinova.anna@gmail.com $1 https://orcid.org/0000000164615977
- 245 10
- $a Prevalence, country-specific prescribing patterns and determinants of benzodiazepine use in community-residing older adults in 7 European countries / $c A. Lukačišinová, J. Reissigová, M. Ortner-Hadžiabdić, J. Brkic, B. Okuyan, D. Volmer, I. Tadić, P. Modamio, EL. Mariño, K. Tachkov, R. Liperotti, G. Onder, H. Finne-Soveri, H. van Hout, EP. Howard, D. Fialová
- 520 9_
- $a BACKGROUND: The use of benzodiazepines (BZDs) in older population is often accompanied by drug-related complications. Inappropriate BZD use significantly alters older adults' clinical and functional status. This study compares the prevalence, prescribing patterns and factors associated with BZD use in community-dwelling older patients in 7 European countries. METHODS: International, cross-sectional study was conducted in community-dwelling older adults (65 +) in the Czech Republic, Serbia, Estonia, Bulgaria, Croatia, Turkey, and Spain between Feb2019 and Mar2020. Structured and standardized questionnaire based on interRAI assessment scales was applied. Logistic regression was used to evaluate factors associated with BZD use. RESULTS: Out of 2,865 older patients (mean age 73.2 years ± 6.8, 61.2% women) 14.9% were BZD users. The highest prevalence of BZD use was identified in Croatia (35.5%), Spain (33.5%) and Serbia (31.3%). The most frequently prescribed BZDs were diazepam (27.9% of 426 BZD users), alprazolam (23.7%), bromazepam (22.8%) and lorazepam (16.7%). Independent factors associated with BZD use were female gender (OR 1.58, 95%CI 1.19-2.10), hyperpolypharmacy (OR 1.97, 95%CI 1.22-3.16), anxiety (OR 4.26, 95%CI 2.86-6.38), sleeping problems (OR 4.47, 95%CI 3.38-5.92), depression (OR 1.95, 95%CI 1.29-2.95), repetitive anxious complaints (OR 1.77, 95%CI 1.29-2.42), problems with syncope (OR 1.78, 95%CI 1.03-3.06), and loss of appetite (OR 0.60, 95%CI 0.38-0.94). In comparison to Croatia, residing in other countries was associated with lower odds of BZD use (ORs varied from 0.49 (95%CI 0.32-0.75) in Spain to 0.01 (95%CI 0.00-0.03) in Turkey), excluding Serbia (OR 1.11, 95%CI 0.79-1.56). CONCLUSIONS: Despite well-known negative effects, BZDs are still frequently prescribed in older outpatient population in European countries. Principles of safer geriatric prescribing and effective deprescribing strategies should be individually applied in older BZD users.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a benzodiazepiny $x škodlivé účinky $7 D001569
- 650 _2
- $a průřezové studie $7 D003430
- 650 _2
- $a prevalence $7 D015995
- 650 12
- $a úzkostné poruchy $7 D001008
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Reissigová, Jindra $u Department of Statistical Modelling, Institute of Computer Science of the Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Ortner-Hadžiabdić, Maja $u Center for Applied Pharmacy, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia
- 700 1_
- $a Brkic, Jovana $u Department of Social and Clinical Pharmacy - Research Group "Ageing, Polypharmacy and Changes in the Therapeutic Value of Drugs in the Aged", Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovského 1203, Hradec Králové, 500 05, Czech Republic $u Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
- 700 1_
- $a Okuyan, Betul $u Department of Clinical Pharmacy, Faculty of Pharmacy, Marmara University, Istanbul, Turkey
- 700 1_
- $a Volmer, Daisy $u Faculty of Medicine, Institute of Pharmacy, University of Tartu, Tartu, Estonia
- 700 1_
- $a Tadić, Ivana $u Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
- 700 1_
- $a Modamio, Pilar $u Clinical Pharmacy and Pharmaceutical Care Unit, Department of Pharmacy and Pharmaceutical Technology, and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain
- 700 1_
- $a Mariño, Eduardo L $u Clinical Pharmacy and Pharmaceutical Care Unit, Department of Pharmacy and Pharmaceutical Technology, and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain
- 700 1_
- $a Tachkov, Konstantine $u Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria
- 700 1_
- $a Liperotti, Rosa $u Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy $u Università Cattolica del Sacro Cuore, Rome, Italy
- 700 1_
- $a Onder, Graziano $u Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy $u Università Cattolica del Sacro Cuore, Rome, Italy
- 700 1_
- $a Finne-Soveri, Harriet $u Finnish Institute for Health and Welfare, Helsinki, Finland
- 700 1_
- $a van Hout, Hein $u Department of General Practice, Amsterdam Public Health Research Institute, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam, The Netherlands
- 700 1_
- $a Howard, Elizabeth P $u Connell School of Nursing, Boston College, Chestnut Hill, MA, USA $u The Hinda and Arthur Marcus Institute for Aging Research (The Marcus Institute), Hebrew Senior Life, Boston, MA, USA
- 700 1_
- $a Fialová, Daniela $u Department of Social and Clinical Pharmacy - Research Group "Ageing, Polypharmacy and Changes in the Therapeutic Value of Drugs in the Aged", Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovského 1203, Hradec Králové, 500 05, Czech Republic $u Department of Geriatrics and Gerontology, 1st Faculty of Medicine in Prague, Charles University, Prague, Czech Republic
- 773 0_
- $w MED00008182 $t BMC geriatrics $x 1471-2318 $g Roč. 24, č. 1 (2024), s. 240
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38454372 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240423155501 $b ABA008
- 999 __
- $a ok $b bmc $g 2081013 $s 1216535
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 24 $c 1 $d 240 $e 20240307 $i 1471-2318 $m BMC geriatrics $n BMC Geriatr $x MED00008182
- GRA __
- $a CZ.02.01.01/00/22_008/0004607 $p NETPHARM New Technologies for Translational Research in Pharmaceutical Sciences
- LZP __
- $a Pubmed-20240412
